Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
“Global Asthma & COPD market set to grow to $49 bn by 2025” says new Visiongain report
The Asthma and COPD market has the potential to bring several blockbuster drugs to the marketplace due to the increasingly segmented sub-groups of patients.
17 February 2020
“Global Rheumatoid Arthritis Drugs market estimated to grow at a CAGR of 0.6% in the second half of the forecast period” says Visiongain report
Another factor driving the growth in the market is the discovery of new molecules that are involved in the disease process, and hence, new strategies for treating the disease.
17 February 2020
Visiongain assesses that the Contract Research Organisations (CROs) market will generate revenues of $38.0 billion in 2020
Global clinical research organizations market was valued at $34.9 billion in 2019 and is projected to grow at a CAGR of 9.5% during the forecast period 2020-2030.
12 February 2020
“Translational Regenerative Medicine market set to grow to $118bn by 2025” says new Visiongain report
The translational regenerative medicine market is expected to grow significantly due to the advances in technology and improvements in regulatory frameworks.
03 February 2020
